In summary (Figure 4), we report here that hepcidin levels were significantly increased during the onset of septic shock, in severe COVID-19, and shortly after major surgery, demonstrating its value as a very early marker of immune system activation in pathogenic and non-pathogenic inflammatory contexts. The gene discussed is HAMP; the disease is COVID-19.